ES2001863A6 - Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos que contienen un atomo de carbono tetrasubstituido, inhibidores de la renina y de las proteasas acidas - Google Patents

Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos que contienen un atomo de carbono tetrasubstituido, inhibidores de la renina y de las proteasas acidas

Info

Publication number
ES2001863A6
ES2001863A6 ES8600722A ES8600722A ES2001863A6 ES 2001863 A6 ES2001863 A6 ES 2001863A6 ES 8600722 A ES8600722 A ES 8600722A ES 8600722 A ES8600722 A ES 8600722A ES 2001863 A6 ES2001863 A6 ES 2001863A6
Authority
ES
Spain
Prior art keywords
renin
carbon atom
pharmaceutical compositions
tetra
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8600722A
Other languages
English (en)
Inventor
Jean Wagnon
Remy Guegan
Colette Lacour
Dino Nisato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES2001863A6 publication Critical patent/ES2001863A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA FABRICACION DE DERIVADOS AMINOALCOHOLES PEPTIDICOS DE FORMULA: ASI COMO LAS SALES FARMACEUTICAMENTE ACEPTABLES DE DICHO AMINOALCOHOL CON LOS ACIDOS MINERALES U ORGANICOS O CON METALES ALCALINOS O ALCALINOTERREOS CARACTERIZADO POR COMPRENDER EL TRATAMIENTO DE UN AMINOALCOHOL DE FORMULA: PROCEDIENDO A CONTINUACION, ETAPA POR ETAPA, AL ALARGAMIENTO DE LA CADENA PEPTIDICA POR ACOPLAMIENTO CON LOS ACIDOS AMINADOS O LOS FRAGMENTOS SIGUIENTES, CONVENIENTEMENTE PROTEGIDOS, SIENDO EFECTUADAS LAS DIFERENTES OPERACIONES UTILIZANDO O BIEN UN ESTER ACTIVADO DEL AMINOACIDO O DEL FRAGMENTO O ACOPLAR O BIEN EL AMINOACIDO N-PROTEGIDO EN PRESENCIA DE DCCI.
ES8600722A 1985-07-31 1986-07-30 Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos que contienen un atomo de carbono tetrasubstituido, inhibidores de la renina y de las proteasas acidas Expired ES2001863A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8511728A FR2585708B1 (fr) 1985-07-31 1985-07-31 Derives aminoalcools peptidiques inhibiteurs de la resine et des proteases acides, leur procede de preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ES2001863A6 true ES2001863A6 (es) 1988-07-01

Family

ID=9321828

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8600722A Expired ES2001863A6 (es) 1985-07-31 1986-07-30 Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos que contienen un atomo de carbono tetrasubstituido, inhibidores de la renina y de las proteasas acidas

Country Status (17)

Country Link
US (1) US4840935A (es)
EP (1) EP0211744B1 (es)
JP (1) JP2505164B2 (es)
KR (1) KR930008111B1 (es)
AT (1) ATE70067T1 (es)
AU (1) AU600907B2 (es)
CA (1) CA1293839C (es)
DE (1) DE3682721D1 (es)
DK (1) DK172011B1 (es)
ES (1) ES2001863A6 (es)
FR (1) FR2585708B1 (es)
GR (1) GR862021B (es)
IE (1) IE59400B1 (es)
IL (1) IL79442A (es)
NZ (1) NZ217007A (es)
PT (1) PT83045B (es)
ZA (1) ZA865696B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222755A (en) * 1986-12-23 1989-11-28 Warner Lambert Co Renin inhibiting acyl peptide derivatives containing two to four amino acid residues, and pharmaceutical compositions
DE3815913A1 (de) * 1988-05-10 1989-11-23 Sandoz Ag Neue reninhemmer, verfahren zu deren herstellung und deren verwendung
DE3841520A1 (de) * 1988-12-09 1990-06-13 Hoechst Ag Enzymhemmende harnstoffderivate von dipeptiden, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
FR2646354B1 (fr) * 1989-04-27 1994-06-10 Sanofi Sa Utilisation de peptides inhibiteurs de proteases acides pour la preparation de medicaments utiles pour le traitement de maladies virales
FR2647675B1 (fr) * 1989-06-05 1994-05-20 Sanofi Utilisation d'un derive de la statine dans le traitement des affections oculaires
JPH0765456B2 (ja) * 1989-12-09 1995-07-19 株式会社奥村組 拡大トンネル部の構築方法
JPH0768844B2 (ja) * 1990-08-24 1995-07-26 鉄建建設株式会社 シールドトンネルの拡巾方法
US5367084A (en) * 1993-10-26 1994-11-22 Iowa State University Research Foundation, Inc. Preparation of pyrrol and oxazole compounds: formation of porphyrins and c-acyl-α-amino acid esters therefrom
US5672717A (en) * 1993-10-26 1997-09-30 Iowa State University Research Foundation, Inc. Preparation of pyrrol and oxazole compounds; formation of porphyrins and C-acyl-α-amino acid esters therefrom
US5863902A (en) * 1995-01-06 1999-01-26 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US5833946A (en) * 1995-06-06 1998-11-10 Bayer Corporation Dissemination of fungal infections: animal model and method of prophylaxis
IL153594A0 (en) * 2000-07-13 2003-07-06 Sankyo Co Amino alcohol derivatives and pharmaceutical compositions containing the same
WO2005105069A1 (en) * 2004-04-26 2005-11-10 Alcon, Inc. Statins for the treatment of ocular hypertension and glaucoma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1245217A (en) * 1981-12-10 1988-11-22 Joshua S. Boger Renin inhibitory peptides having phe su13 xx deletion
US4595677A (en) * 1982-12-03 1986-06-17 Ciba-Geigy Corporation Substituted tetrapeptides
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
US4668663A (en) * 1984-03-27 1987-05-26 Merck & Co., Inc. Renin inhibitors containing homophe8
US4636491A (en) * 1984-03-27 1987-01-13 Merck & Co., Inc. Renin inhibitory peptides having improved solubility
DE3418491A1 (de) * 1984-05-18 1985-11-21 Merck Patent Gmbh, 6100 Darmstadt Diaminosaeurederivate
CA1286846C (en) * 1985-02-12 1991-07-23 Catherine Cazaubon Peptide derivatives which inhibit renin and acid proteases

Also Published As

Publication number Publication date
JP2505164B2 (ja) 1996-06-05
JPS6229596A (ja) 1987-02-07
PT83045A (fr) 1986-08-01
NZ217007A (en) 1988-06-30
EP0211744A1 (fr) 1987-02-25
GR862021B (en) 1986-12-31
KR930008111B1 (ko) 1993-08-26
IL79442A (en) 1991-06-10
AU6052086A (en) 1987-02-05
EP0211744B1 (fr) 1991-12-04
IE862031L (en) 1987-01-31
PT83045B (pt) 1988-07-01
IE59400B1 (en) 1994-02-23
ZA865696B (en) 1987-03-25
FR2585708B1 (fr) 1989-07-07
ATE70067T1 (de) 1991-12-15
DK364486A (da) 1987-02-01
KR880001697A (ko) 1988-04-26
CA1293839C (en) 1991-12-31
IL79442A0 (en) 1986-10-31
FR2585708A1 (fr) 1987-02-06
DK364486D0 (da) 1986-07-31
US4840935A (en) 1989-06-20
DE3682721D1 (de) 1992-01-16
AU600907B2 (en) 1990-08-30
DK172011B1 (da) 1997-09-15

Similar Documents

Publication Publication Date Title
ES2001863A6 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos que contienen un atomo de carbono tetrasubstituido, inhibidores de la renina y de las proteasas acidas
ES8203385A1 (es) Procedimiento de obtencion de nuevos derivados de la vin- blastina
ES8800051A1 (es) Un procedimiento para la preparacion de derivados de cetona electrofilicos activados de sustratos de peptidasa, utiles en la inhibicion de enzimas proteasas
BR9713366A (pt) Análogos de heptapeptìdeo oxitocina
MY137301A (en) Peptide analogs as irreversible interleukin-1b protease inhibitors
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
ES2000852A6 (es) Un nuevo procedimiento para preparar intermediarios con residuos de acido 5-amino-2,5-disustituido -4- hidroxipentanoico,utiles en la sintesis de polipeptidos inhibidores de renina.
NZ214122A (en) Analgesic dynorphin-like hepta and octa and nona and deca peptides
PL309629A1 (en) Atovaquone containing pharmaceutical compositions
IL75637A0 (en) Thymopentin analogs and pharmaceutical compositions containing them
GR860399B (en) Process for obtaining peptidic derivatives pepstatine analogs renines inhibitors and proteases acids
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
HUT71798A (en) Process for preparing pharmaceutical compositions of antidepressant activity containing 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol)
PT77370A (en) Process for preparing new pyrazolo <3,4-b> piridine derivatives and pharmaceutical preparations containing the same
ES2012119A6 (es) Procedimiento para la produccion de supositorios a base de calcitoninas.
EP0206090A3 (en) Peptide renin inhibitors
GR3018096T3 (en) Polypeptide comprising repeated cell-adhesive core sequences.
ES8601236A1 (es) Un procedimiento para la preparacion de derivados peptidicos
ES8601915A1 (es) Un procedimiento para preparar derivados de piridazinona
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
AU579593B2 (en) Novel peptides which are active on the central nervous system and have an action on the cholinergic system
IL105669A0 (en) Dithiolanylglycine-containing hiv protease inhibitors of the hydroxyethylene isostere type,their preparation and pharmaceutical compositions containing them
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
GB8504357D0 (en) Peptide
DE3867039D1 (de) Vincristin enthaltendes produkt.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000601